Society guideline links: Hyperthyroidism

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thyroid disease and pregnancy".)

Canada

●Choosing Wisely Canada: Don't order thyroid function tests as screening for asymptomatic, low risk patients (updated 2021)

●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care (2019)

United States

●Choosing Wisely: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland. However, thyroid vascularity assessed by color flow doppler in patients with overt hyperthyroidism (elevated free T4 and T3 and suppressed TSH) may help distinguish Graves' hyperthyroidism and toxic nodular goiter from a destructive thyroiditis (painless, painful, or drug induced) (2013, updated 2022)

●American Association of Endocrine Surgeons (AAES): Guidelines for the definitive surgical management of thyroid disease in adults (2020)

●American College of Obstetricians and Gynecologists (ACOG): Practice bulletin on thyroid disease in pregnancy (2020)

●Choosing Wisely: Avoid Thyroid Stimulating Hormone (TSH) screening in annual well-visits for asymptomatic adults, regardless of age (2020)

●American Thyroid Association (ATA): Guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum (2017)

●ATA: Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis (2016)

●ATA: Practice recommendations for radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I (2011)

Europe

●European Thyroid Association (ETA): Guideline for the management of pediatric Graves' disease (2022)

●ETA: Guideline on thyroid disorders prior to and during assisted reproduction (2021)

●ETA: Guidelines for the management of iodine-based contrast media-induced thyroid dysfunction (2021)

●European Group on Graves' Orbitopathy (EUGOGO): Clinical practice guidelines for the medical management of Graves' orbitopathy (2021)

●ETA: Guidelines on the management of thyroid dysfunction following immune reconstitution therapy (2019)

●ETA: Guideline for the management of Graves' hyperthyroidism (2018)

●ETA: Guidelines for the management of amiodarone-associated thyroid dysfunction (2018)

●ETA: Guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism (2015)

●ETA: Guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations (2012)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on thyroid disease – Assessment and management (2019)

●NICE: Interventional procedures guidance – Minimally invasive video-assisted thyroidectomy (2014)

Australia-New Zealand

●Choosing Wisely Australia: Don't test thyroid function as population screening for asymptomatic patients (reviewed 2016)

●Choosing Wisely Australia: Don't routinely order a thyroid ultrasound in patients with abnormal thyroid function tests if there is no palpable abnormality of the thyroid gland (reviewed 2015)